Delivery Order SPE2DB25D3002-SPE2DB25FLQPB
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,603.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Trulicity, a diabetes medication, with a performance period through May 2025. This contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support...
This federal contract award, valued at $1,351.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity, a diabetes medication, under a Firm Fixed Price contract type. The contract has an ultimate completion date of April 24, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,102.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity, a diabetes medication, with an ultimate completion date of April 24, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger...
This federal contract award, valued at $1,801.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity, a 3 mg/0.5 ml diabetes medication, with a performance period through April 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,144.54, is for the supply of the diabetes medication Trulicity 0.75 mg/0.5 ml pen with a completion date of February 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,459.60 firm fixed-price delivery order is for the supply of Trulicity, a diabetes medication, with a performance period through April 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of the drug Trulicity, a medication used to manage diabetes, with a ceiling value of $4,089.11. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a period of performance through November 2024. This award is a part of Amerisourcebergen's larger...
This federal contract award, valued at $12,903.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Trulicity, a medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2025. This contract is not set-aside and represents an open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $2,552.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the medication Trulicity 1.5 mg/0.5 ml pen, a treatment for diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity, a diabetes treatment medication, with a ceiling value of $2,766.23 and a performance period through April 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which has a total potential value of...